TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of Infectious Disease
Division of General Internal Medicine
National Taiwan University Hospital Yunlin Branch
Division of General Internal Medicine
更新時間：2023-09-19
洪健清HUNG, CHIEN-CHING
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
Publication
85Publications
61
Wu PY, Cheng CY, Liu CE, Lee YC, Yang CJ, Tsai MS, Cheng SH, Lin SP, Lin DY, Wang NC, Lee YC, Sun HY, Tang HJ, Hung CC. Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan. PLoS One. 2017 Feb 21;12(2):e0171596. doi: 10.1371/journal.pone.0171596. PMID: 28222098; PMCID: PMC5319792.
62
Huang SH, Lin SW, Chang SY, Lin YT, Chiang C, Hsiao CF, Sun HY, Liu WC, Su YC, Hung CC, Chang SC. Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy. Sci Rep. 2017 Nov 23;7(1):16187. doi: 10.1038/s41598-017-16483-2. PMID: 29170492; PMCID: PMC5701031.
63
Lee YL, Lin KY, Cheng CY, Li CW, Yang CJ, Tsai MS, Tang HJ, Lin TY, Wang NC, Lee YC, Lin SP, Huang YS, Sun HY, Zhang JY, Ko WC, Cheng SH, Lee YT, Liu CE, Hung CC; Taiwan HIV Study Group. Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan. PLoS One. 2017 Oct 16;12(10):e0186338. doi: 10.1371/journal.pone.0186338. PMID: 29036227; PMCID: PMC5643057.
64
Wu UI, Hung CC, Chang SY, Jhong YT, Sun HY, Wang JT, Hsieh SM, Sheng WH, Liu WC, Chang SC, Chen YC. Neutralizing antiinterferon-γ autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapy. AIDS. 2017 Nov 28;31(18):2557-2559. doi: 10.1097/QAD.0000000000001644. PMID: 29120902.
65
Cheng A, Chang SY, Sun HY, Tsai MS, Liu WC, Su YC, Wu PY, Hung CC, Chang SC. Long-term Durability of Responses to 2 or 3 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus-Positive Adults on Antiretroviral Therapy. J Infect Dis. 2017 Feb 15;215(4):606-613. doi: 10.1093/infdis/jiw605. PMID: 28011921.
66
Tsai MS, Chang SY, Lin SW, Kuo CH, Sun HY, Wu BR, Tang SY, Liu WC, Su YC, Hung CC, Chang SC. Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study. J Microbiol Immunol Infect. 2017 Dec;50(6):789-797. doi: 10.1016/j.jmii.2015.12.012. Epub 2016 Jan 11. PMID: 26857335.
67
Lin KY, Cheng CY, Li CW, Yang CJ, Tsai MS, Liu CE, Lee YT, Tang HJ, Wang NC, Lin TY, Lee YC, Lin SP, Huang YS, Zhang JY, Ko WC, Cheng SH, Hung CC; Taiwan HIV Study Group. Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up. PLoS One. 2017 Jun 30;12(6):e0179870. doi: 10.1371/journal.pone.0179870. PMID: 28665938; PMCID: PMC5493332.
68
Huang YS, Chan CK, Tsai MS, Lee KY, Lin SW, Chang SY, Hung CC, Chang SC. Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients. J Microbiol Immunol Infect. 2017 Oct;50(5):595-603. doi: 10.1016/j.jmii.2015.08.019. Epub 2015 Sep 9. PMID: 26514942.
69
Lin KY, Chen GJ, Lee YL, Huang YC, Cheng A, Sun HY, Chang SY, Liu CE, Hung CC. Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review. World J Gastroenterol. 2017 May 28;23(20):3589-3606. doi: 10.3748/wjg.v23.i20.3589. PMID: 28611512; PMCID: PMC5449416.
70
Huang YS, Yang JJ, Lee NY, Chen GJ, Ko WC, Sun HY, Hung CC. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review. Expert Rev Anti Infect Ther. 2017 Sep;15(9):873-892. doi: 10.1080/14787210.2017.1364991. Epub 2017 Aug 21. PMID: 28782390.
